GuruFocus.com
Balchem Corp (BCPC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Partnerships ...
📈
AI Sentiment
Highly Positive
9/10
- Home
- BCPC
BCPC
Balchem Corporation
as of 02-26-2026 3:51pm EST
$180.10
+$0.48
+0.27%
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
| Founded: | 1967 | Country: | United States |
| Employees: | 1355 | City: | MONTVALE |
| Market Cap: | 5.8B | IPO Year: | 1995 |
| Target Price: | $176.00 | AVG Volume (30 days): | 141.8K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | annual | |
| EPS: | 4.75 | EPS Growth: | 20.87 |
| 52 Week Low/High: | $139.17 - $183.01 | Next Earning Date: | 05-25-2026 |
| Revenue: | $799,023,000 | Revenue Growth: | 13.56% |
| Revenue Growth (this year): | 7.99% | Revenue Growth (next year): | 2.77% |
| P/E Ratio: | 37.81 | Index: | N/A |
| Free Cash Flow: | 167.5M | FCF Growth: | +18.27% |
AI-Powered BCPC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.80%
75.80%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Balchem Corporation (BCPC)
van Gunsteren Job Leonard
Sell
SVP and GM, Specialty Products
BCPC Dec 4, 2025
Avg Cost/Share
$153.44
Shares
6,000
Total Value
$919,722.53
Owned After
11,211
Fischer David B
Sell
Director
BCPC Dec 3, 2025
Avg Cost/Share
$154.03
Shares
8,000
Total Value
$1,231,748.20
Owned After
9,989
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| van Gunsteren Job Leonard | BCPC | SVP and GM, Specialty Products | Dec 4, 2025 | Sell | $153.44 | 6,000 | $919,722.53 | 11,211 | |
| Fischer David B | BCPC | Director | Dec 3, 2025 | Sell | $154.03 | 8,000 | $1,231,748.20 | 9,989 |
Latest Balchem Corporation News
BCPC Breaking Stock News: Dive into BCPC Ticker-Specific Updates for Smart Investing
MT Newswires
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Digest Key Economic Data, Geopolitical Tensions
âž–
AI Sentiment
Neutral
5/10
Investing.com
Balchem stock up over 4% Record Q4 and Full-Year Results
📈
AI Sentiment
Highly Positive
10/10
MT Newswires
Balchem's Q4 Adjusted Earnings, Net Sales Increase
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
📈
AI Sentiment
Highly Positive
10/10
Compare BCPC vs Leading Stocks
See how BCPC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BCPC Balchem Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.